[ABO immunological afectation of newborns, between heterospecific ABO pregnancy and haemolytic ABO disease. A study of 156 cases (author's transl)].
D000017:ABO Blood-Group System; D000373:Agglutinins / Q000032:analysis; D000906:Antibodies / Q000032:analysis; D004899:Erythroblastosis, Fetal / Q000276:immunology*; D005260:Female; D006460:Hemolysin Proteins / Q000032:analysis; D006801:Humans; D007231:Infant, Newborn; D007232:Infant, Newborn, Diseases / Q000276:immunology*; D011247:Pregnancy; D011250:Pregnancy Complications, Hematologic / Q000276:immunology*
D000017:ABO Blood-Group System; D000373:Agglutinins; D000906:Antibodies; D006460:Hemolysin Proteins
La afectación inmunológica neonatal (ABO) entre el embarazo heteroespecífico (ABO) y la enfermedad hemolítica (ABO).